OMB is approving this Emergency ICR with the understanding that within 5 months from the approval date, CDC will complete a 60d and 30d public comment request to support the approval of the ICR ahead of the expiration date.
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2025
5 Months From Approved
7,350
0
0
630
0
0
0
0
0
In September 2024, an outbreak of Marburg virus was detected in the Republic of Rwanda. CDC plans to conduct public health entry screening at designated U.S. airports of travelers coming from areas experiencing an outbreak of Marburg originating in Rwanda. The purpose of this Emergency ICR is to inform CDC and interagency decision makers on state/local health department activities related to travelers coming from areas affected by a Marburg outbreak originating in Rwanda. This information will be used to 1) gather feedback from state and local health department partners on CDCâs interim guidance and post-arrival management of travelers; 2) assess the quality of contact information provided to states by determining the proportion of travelers that state and local health departments were able to contact for recommended assessment and monitoring; and 3) inform the development of future guidance and recommendations for post-arrival traveler management during viral hemorrhagic fever outbreaks abroad.
The goal of this information collection is to determine the number of travelers coming to the United States from Rwanda, where a Marburg outbreak is occurring, that are enrolled by jurisdictions into monitoring, if recommended, and the proportion of travelers that completed monitoring.
To further protect U.S. communities from an imported case of Marburg, the United States must be prepared to respond domestically by providing state and local health departments and healthcare facilities with the necessary assessments and questionnaires that can assist in identifying high-risk exposures in travelers arriving from areas affected by the outbreak. CDC proposes to conduct this assessment to determine the proportion of travelers that state and local health departments were able to contact for traveler monitoring and inform the develop of future guidance and recommendations for traveler monitoring.
CDC requests authorization to collect information under Emergency Processing Guidelines from state and local health departments to mitigate the risk of transmission and spread of Marburg to the United States. If an emergency approval is not granted, then the spread of Marburg to the United States is more likely.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
MVD Final Survey
Emergency Request Memo_2024 Marburg Traveler Monitoring Assessment_REVISED.docx
Attachment F- IRB Non-Research Determination.pdf
MVD Final Survey